Biocytogen HK$549 million IPO
We advised Biocytogen on its IPO and HKEX listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Red Star Macalline Group $249.7 million credit enhanced bonds offering
We advised the issuer on the credit enhanced bonds offering
Akeso HK$582 million share placement
We advised Akeso in the placement of new shares
Tuya global offering and dual primary listing on the Hong Kong Stock Exchange
We advised Tuya Inc. on its HK$141 million global offering and dual primary listing on the HKEX
Jiangsu Zhongnan Construction Group exchange offers
The exchange offers involve guaranteed senior notes due this year
Gracell Biotechnologies at-the-market offering
The ADSs are listed on the Nasdaq Global Select Market
Li Auto $2 billion at-the-market offering
This is the first at-the-market offering by a U.S.-listed issuer with a dual primary listing in Hong Kong
Tencent renewed strategic cooperation with JD.com
We are advising Tencent on the renewal of the strategic cooperation agreement and purchase of ordinary shares of JD.com
Leading Holdings exchange offer
The exchange offer is for the issuer’s outstanding 12% senior notes due 2022
Jiangsu Zhongnan Construction Group exchange offers and consent solicitation
The exchange offers and consent solicitation are for guaranteed senior notes